Keywords: SuperGen, Astex Therapeutics, M&A, Cancer

Astex Thera to merge into SuperGen in cash and stock deal

Article | 08 April 2011

Print This

USA-based cancer drug developer SuperGen (Nasdaq: SUPG) and privately-held UK biotech firm Astex Therapeutics have entered into a definitive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in